Fusicoccin 31
(2S,3R,4S,5S,6R)-2-[[(1Z,3R,4S,8R,9R,11S,14S)-4,9-dihydroxy-14-(methoxymethyl)-3,11-dimethyl-6-[(2S)-1-piperidin-1-ylpropan-2-yl]-8-tricyclo[9.3.0.03,7]tetradeca-1,6-dienyl]oxy]-6-(2-methylbut-3-en-2-yloxymethyl)oxane-3,4,5-triol
Molecular Identity
Fusicoccin 31
(2S,3R,4S,5S,6R)-2-[[(1Z,3R,4S,8R,9R,11S,14S)-4,9-dihydroxy-14-(methoxymethyl)-3,11-dimethyl-6-[(2S)-1-piperidin-1-ylpropan-2-yl]-8-tricyclo[9.3.0.03,7]tetradeca-1,6-dienyl]oxy]-6-(2-methylbut-3-en-2-yloxymethyl)oxane-3,4,5-triol
PubChem CID: 171666066
2D Structure
Properties
C37H61NO9
Molecular Formula
663.90
Molecular Weight
g/mol
663.4346
Exact Mass
Da
1.5
XLogP
Drug-like (Lipinski: < 5)
141
TPSA
May have limited oral absorption
5
H-Bond Donors
10
H-Bond Acceptors
1170
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(3)
Fusicoccin 31YTAKJTRHNAPYIG-SNBKJTGRSA-NSJC
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Fusicoccin 31
Loading drug network...